JDRF touts win after Anthem decides to cover artificial pancreas systems

JDRF said today it successfully persuaded Anthem to cover artificial pancreas systems, after meeting the health insurer as part of is Coverage2Control campaign.

America’s 25 largest health insurers now cover Medtronic‘s (NYSE:MDT) MiniMed system, according to the organization.

Get the full story at our sister site, Drug Delivery Business News.

The post JDRF touts win after Anthem decides to cover artificial pancreas systems appeared first on MassDevice.

from MassDevice http://ift.tt/2hzi8Qp